Hydrophilic Angiographic Catheters Market Report 2024

This Hydrophilic Angiographic Catheters market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The hydrophilic angiographic catheters market size has grown strongly in recent years. It will grow from $11.75 billion in 2023 to $12.6 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. The growth observed in the past can be linked to the increasing incidence of cardiovascular diseases, the rising number of peripheral vascular diseases, a higher frequency of diagnostic and interventional procedures, improved awareness and early detection, and growing healthcare expenditures.

The hydrophilic angiographic catheters market size is expected to see strong growth in the next few years. It will grow to $16.7 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The anticipated growth is driven by factors such as an aging population, a preference for minimally invasive procedures, a higher prevalence of diabetes, and increased investment in cardiovascular research. Key trends expected during the forecast period include technological innovations, expansion into new markets, advancements in imaging technology, increased applications in oncology, and a focus on minimally invasive techniques.

The rise in renal disorders is anticipated to drive the expansion of the hydrophilic angiographic catheters market in the future. Renal disorders encompass a range of conditions that disrupt the kidneys' ability to filter blood, eliminate waste, balance fluids and electrolytes, and regulate blood pressure. The increasing prevalence of factors such as diabetes, hypertension, and an aging population is contributing to the growth of renal disorders. Hydrophilic angiographic catheters facilitate precise and smooth navigation during diagnostic and interventional procedures such as renal artery angiography and stenting. For example, a report from Kidney Research UK published in June 2023 indicates that around 7.2 million people in the UK have chronic kidney disease, making up more than 10% of the population. Among these, 3.25 million are in advanced stages, while 3.9 million are in earlier stages. It is projected that by 2033, the number of people with chronic kidney disease will increase to 7.61 million. Consequently, the rising incidence of renal disorders is fueling the growth of the hydrophilic angiographic catheters market.

Leading companies in the hydrophilic angiographic catheters market are concentrating on developing innovative products, such as catheters with various curve configurations, to maintain their market position. These specialized catheters are designed with different bending shapes to navigate complex anatomical structures. For instance, in January 2024, Cook Group Incorporated, a US-based medical device company, introduced its Slip-Cath Beacon Tip hydrophilic selective catheter in the USA and Canada. This catheter is suited for both vascular and non-vascular angiographic procedures, offering over 30 different curve configurations and packaging that ensures durability with a three-year shelf life. Its advanced design improves usability during procedures and is compatible with vascular access sheaths, wire guides, and various treatment devices.

In April 2024, Shenzhen Mindray Technology Holdings Co. Ltd., a medical device company based in China, acquired a 19.72% stake in APT Medical for $927 million. This acquisition strengthens Mindray's position in the cardiovascular medical device market, enabling it to benefit from APT Medical's expertise in cardiac electrophysiology and vascular interventions. APT Medical, also based in China, specializes in providing hydrophilic angiographic catheters.

Major companies operating in the hydrophilic angiographic catheters market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Cook Medical Inc., Teleflex Incorporated, BIOTRONIK SE & Co. KG, Lepu Medical Technology (Beijing) Co Ltd., Merit Medical Systems Inc., Cordis Corporation, MicroPort Scientific Corporation, Asahi Intecc Co Ltd., AngioDynamics Inc., Biosensors International Group Ltd., Alvimedica Medical Technologies, BrosMed Medical Co Ltd., iVascular SLU, Reva Medical Inc., Hexacath, Translumina Therapeutics LLP, Eurocor Tech GmbH, Invamed Group.

Asia-Pacific was the largest region in the hydrophilic angiographic catheters market in 2023. The regions covered in the hydrophilic angiographic catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hydrophilic angiographic catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Hydrophilic angiographic catheters are advanced medical tools used in interventional radiology and cardiology. They are coated with a hydrophilic material that greatly decreases friction, allowing for smoother passage through intricate vascular networks. This coating enhances the ease of handling and control during diagnostic and therapeutic procedures for cardiovascular conditions.

There are two main types of hydrophilic angiographic catheters selective and non-selective. Selective catheters are engineered for precise access to specific blood vessels and come with various tip shapes and curves to navigate complex vascular structures and reach target vessel openings. They are utilized in treatments for conditions such as heart and kidney diseases, and are employed by a range of end users including hospitals, diagnostic centers, and imaging facilities.

The hydrophilic angiographic catheters market research report is one of a series of new reports that provides hydrophilic angiographic catheters market statistics, including hydrophilic angiographic catheters industry global market size, regional shares, competitors with a hydrophilic angiographic catheters market share, detailed hydrophilic angiographic catheters market segments, market trends and opportunities, and any further data you may need to thrive in the hydrophilic angiographic catheters industry. This hydrophilic angiographic catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hydrophilic angiographic catheters market consists of sales of guidewire, imaging equipment, contrast media injectors, and control and steering devices. The market value includes the value of related goods sold by the service provider or included within the service offering. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.